Abstract
The aging process influences and modifies the clinical picture and treatment modalities of inflammatory pancreatic diseases in elderly patients. The two major categories of inflammatory exocrine pancreatic diseases seen in the elderly are acute pancreatitis (AP) and chronic pancreatitis (CP).
In elderly patients with AP, the presence of concomitant diseases affecting renal, hepatic and cardiopulmonary function make the early clinical assessment of the severity of AP inaccurate at the time of admission to hospital. In addition, the classical multifactorial scoring system routinely utilised in clinical practice to determine the severity of AP may overscore elderly patients because increasing age is associated with more points. Contrast-enhanced computed tomography is particularly useful in assessing the severity of AP and is required in all patients suspected with severe AP. It should be repeated after a certain time period to monitor the disease. The most important aspect of the management of elderly patients with severe AP is the prevention and treatment of systemic and local complications. Treatment of AP should address the removal of aetiological factor(s) and support of organ systems and hydroelectrolytic/caloric balance; specific treatments (antiproteases, antibacterials) should also be administered to patients with severe AP. Surgery is indicated mainly when infection occurs following pancreatic necrosis and/or fluid collection. However, in selected patients with a high anaesthetic risk, alternative, less invasive drainage options (percutaneous, endoscopic) should be considered.
CP rarely occurs in older age, and it should be suspected based on clinical findings. The greatest challenge is the differentiation between CP and pancreatic cancer. Treatment of CP in the elderly should be directed at controlling the symptoms, by management of diabetes and exocrine insufficiency because pain and complications are rare in elderly patients with CP. Compliance with treatment should be periodically assessed if insulin and/or oral enzyme supplementation is required. Careful evaluation of nutritional status and its prompt correction is also important.
Similar content being viewed by others
References
Uomo G, Talamini G, Rabitti PG, et al. Influence of advanced age and related comorbidity on the course and outcome of acute pancreatitis. Ital J Gastroenterol Hepatol 1998; 30: 616–21
Bradley EL. A clinically based classification system for acute pancreatitis. Arch Surg 1993; 128: 586–90
Steinberg W, Tenner S. Acute pancreatitis. N Engl J Med. 1994; 330: 1198–210
Sargen K, Kingsnorth AN. Management of gallstone pancreatitis: effects of deviation from clinical guidelines [online]. JOP 2001; 2(5): 317–22. Available from URL: http://www.joplink.net/prev/200109/03_c.html [Accessed 2002 Oct 11]
Cavallini G, Uomo G, Pezzilli R, et al. Acute pancreatitis in Italy: a multicenter study on 1005 patients. Pancreatology 2001; 1: 167
Lankisch PG. Epidemiology of acute pancreatitis. In: Büchler MW, Uhl W, Friess H, et al., editors. Acute pancreatitis-novel concepts in biology and therapy. Berlin: Blackwell Science, 1999: 145–53
Go VLW. Etiology and epidemiology of pancreatitis in the United States. In: Bradley EL, editor. Acute pancreatitis: diagnosis and therapy. New York: Raven Press, 1994: 235–9
Dominguez-Muñoz JE. Diagnosis of acute pancreatitis: any news or still amylase? In: Büchler MW, Uhl W, Friess H, et al., editors. Acute pancreatitis-novel concepts in biology and therapy. Berlin: Blackwell Science, 1999: 171–9
Sternby B, O’Brien JF, Zinsmeister AR. What is the best biochemical test to diagnose acute pancreatitis? A prospective clinical study. Mayo Clin Proc 1996; 71: 1138–44
Dervenis C. Assessments of severity and management of acute pancreatitis based on the Santorini Consensus Conference report [online]. JOP 2001; 1(4): 178–82. Available from URL: http://www.joplink.net/prev/200011/edit.html [Accessed 2002 Oct 11]
Uomo G, Manes G, Rabitti PG. Clinical value of multifactorial classification in the prognostic evaluation of acute pancreatitis. In: Malfertheiner P, Dominguez-Munõz JE, Schulz HU, et al., editors. Diagnostic procedures in pancreatic disease. Berlin: Springer-Verlag, 1997: 97–107
Imrie CW. Assessment of severity of acute pancreatitis. In: Dervenis C, editor. Advances in pancreatic disease. Stuttgart: Georg Thieme Verlag, 1996: 132–7
Bardaji M, Cugar E, Almenara R. Prediction of outcome in acute pancreatitis: three multifactorial systems and C-reactive protein. Proceedings of World Congress of International Hepato-Pancreato-Biliary Association, 1994 May; Los Angeles
Ranson JHC. The timing of biliary surgery in acute pancreatitis. Ann Surg 1979; 189: 654–62
Blamey SL, Imrie CW, O’Neil J, et al. Prognostic factors in acute pancreatitis. Gut 1984; 25: 1340–6
Wilson C, Heath DI, Imrie CW. Prediction of outcome in acute pancreatitis: a comparative study of APACHE II, clinical assessment and multiple factor scoring systems. Br J Surg 1990; 77: 1260–4
Talamini G, Uomo G, Pezzilli R, et al. Serum creatinine and chest radiographs in the early assessment of acute pancreatitis. Am J Surg 1999; 177: 7–14
Balthazar EJ, Robinson DL, Megibow AJ, et al. Acute pancreatitis: value of CT in establishing prognosis. Radiology 1990; 174: 331–6
McKay CJ, Evans S, Sinclair M, et al. High early mortality rate from acute pancreatitis in Scotland, 1984–1995. Br J Surg 1999; 86: 1302–5
Uomo G, Pezzilli R, Cavallini G, et al. I.S.P. Study Group. Management of acute pancreatitis in clinical practice. Ital J Gastroenterol Hepatol 1999; 31: 635–42
British Society of Gastroenterology. United Kingdom guidelines for the management of acute pancreatitis. Gut 1998; 42Suppl. 2: S1–S13
Banks PA. Practice guidelines in acute pancreatitis. Am J Gastroenterol 1997; 92: 377–86
Uomo G, Slavin J. Endoscopic sphincterotomy for acute pancreatitis arguments in favour. Ital J Gastroenterol Hepatol 1998; 30: 557–61
Mergener K, Baille J. Endoscopic treatment for acute biliary pancreatitis. Gastroenterol Clin North Am 1999; 28: 601–13
Enns R, Baille J. Review article: the treatment of acute biliary pancreatitis. Aliment Pharmacol Ther 1999; 13: 1379–89
Uomo G, Manes G, Laccetti M, et al. Endoscopic sphincterotomy and recurrence of acute pancreatitis in gallstone patients considered unfit for surgery. Pancreas 1997; 14: 28–31
Sharma VK, Howden CW. Metaanalysis of randomized controlled trials of controlled trials of endoscopic retrograde cholangiopancreatography and endoscopic sphincterotomy for the treatment of acute biliary pancreatitis. Am J Gastroenterol 1999; 94: 3211–4
Sigurdsson GH. Intensive care management of acute pancreatitis. Dig Surg 1994; 11: 231–41
Norton ID, Clain JE. Optimising outcomes in acute pancreatitis. Drugs 2001; 61: 1581–91
Windsor ACJ, Kanwar S, Li AGK, et al. Compared with parenteral nutrition, enteral feeding attenuates the acute phase response and improves disease severity in acute pancreatitis. Gut 1998; 42: 431–5
Messori A, Rampazzo R, Olivato R, et al. Effectiveness of gabexate mesilate in acute pancreatitis: a metaanalysis. Dig Dis Sci 1995; 40: 734–8
McKay CJ, Baxter JN, Imrie CW. A randomized controlled trial of octreotide in the management of patients with acute pancreatitis. Int J Pancreatol 1997; 21: 13–9
Uhl W, Buchler MW, Malfertheiner P, et al. A randomised, double blind, multicenter trial of octreotide in moderate to severe acute pancreatitis. Gut 1999; 45: 97–104
Johnson CD, Kingsnorth AN, Imrie CW, et al. Double blind, randomised, placebo controlled study of a platelet activating factor antagonist, lexipafant, in the treatment and prevention of organ failure in predicted severe acute pancreatitis. Gut 2001; 48: 62–9
Rünzi M, Layer P. Nonsurgical management of acute pancreatitis: use of antibiotics. Surg Clin North Am 1999; 79:759–65
Golub R, Siddiqi F, Pohl D. Role of antibiotics in acute pancreatitis: a meta-analysis. J Gastrointest Surg 1998; 2: 496–503
Bassi C, Falconi M, Talamini G, et al. Controlled clinical trial of pefloxacin versus imipenem in severe acute pancreatitis. Gastroenterology 1998; 115: 1513–7
Gloor B, Müller CA, Worni M, et al. Pancreatic infection in severe pancreatitis. The role of fungus and multiresistant organisms. Arch Surg 2001; 136: 592–6
Uomo G, Visconti M, Manes G, et al. Nonsurgical treatment of acute necrotizing pancreatitis. Pancreas 1996; 12: 142–8
Uomo G, Molino D, Visconti M, et al. The incidence of main pancreatic duct disruption in severe biliary pancreatitis. Am J Surg 1998; 176: 49–52
Insenmann R, Rau B, Zoellner U, et al. Management of patients with extended pancreatic necrosis. Pancreatology 2001; 1: 63–8
Baron TH, Morgan DE. Acute necrotizing pancreatitis. N Engl J Med 1999; 340: 1412–7
The Copenhagen Pancreatitis Study Group. An interim report from a prospective epidemiological multicenter study. Scand J Gastroenterol 1981; 16: 305–12
O’Sullivan JN, Nobrega FT, Morlock CG, et al. Acute and chronic pancreatitis in Rochester Minnesota 1940 to 1969. Gastroenterology 1972; 62: 373–9
Frezza M, Di Padova C, Pozzato G, et al. High blood alcohol levels in women. N Engl J Med 1990; 323: 95–9
Sarner M. Classification of chronic pancreatitis. In: Johnson CD, Imrie CW, editors. Pancreatic disease-progress and prospects. London: Springer-Verlag, 1991: 171–6
Beger HG, Büchler M, Dischuneit H, et al., editors. Chronic pancreatitis. Berlin: Springer-Verlag, 1990
Di Magno EP, Layer P, Clain JE. Chronic pancreatitis. In: Go VLW, DiMagno EP, Gardner JD, et al., editors. The pancreas. Biology, pathobiology and disease. 2nd ed. New York: Raven Press, 1993: 707–40
Pederzoli P, Cavallini G, Bassi C, editors. Facing the pancreatic dilemma. Berlin: Springer-Verlag, 1994
Amman RW. Chronic pancreatitis in the elderly. Gastroenterol Clin North Am 1990; 19: 905–14
Uomo G, Rabitti PG. Chronic pancreatitis: relation to acute pancreatitis and pancreatic cancer. Ann Ital Chir 2000; 71: 17–21
Procacci C, Graziani R, Bicego E, et al. Intraductal mucinproducing tumors of the pancreas. Radiology 1996; 198: 249–57
Dominguez-Muñoz JE, Hieronymus C, Sauerbruch T, et al. Fecal elastase test: evaluation of a new non-invasive pancreatic function test. Am J Gastroenterol 1995; 90: 1834–7
Acknowledgements
The author has provided no information on sources of funding or on conflicts of interest directly relevant to the content of this review.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Uomo, G. Inflammatory Pancreatic Diseases in Older Patients. Drugs Aging 20, 59–70 (2003). https://doi.org/10.2165/00002512-200320010-00004
Published:
Issue Date:
DOI: https://doi.org/10.2165/00002512-200320010-00004